Overview
Background
After graduating from the University of Melbourne in 1997, Allison spent 2 years in mixed practice in Gawler, SA, before traveling to the USA to undertake a residency in Large Animal Internal Medicine at the Ohio State University. She completed her Masters of Science and was awarded Diplomate status of the American College of Veterinary Internal Medicine (ACVIM) in 2002. She then became a faculty member at Auburn University in Alabama and competed a fellowship in Emergency and Critical Care and obtained Diplomate status in 2007. Allison worked as a specialist and taught veterinary students at Auburn University for 12 years, and has over 300 publications/book chapters/scientific presentations/conference lectures. She was awarded 30 research grants and has presented research throughout the world in the areas of equine endocrinology, fungal disease, neurology, infectious disease and pharmacology. Allison resigned her position as Professor of Equine Medicine at Auburn University in 2015 and moved back to Australia. She spent some time in small animal, mixed and equine practice seeing primarily emergency cases whlist actuing as a Director on the Veterinary Surgeons Board of Victoria. She then completed her PhD at the Swedish Agricultural University in Uppsala and commenced as a Senior Lecturer at the University of Queensland's School of Veterinary Science. Allison enjoys speaking at international conferences. Her current research interests include equine endocrinology, pharmacokinetics and tthe local Queensland specific probelms of Hendra virus diagnsotics and vaccination responses and treatment of Insect Bite Hypersensitivity. Because of her broad prior experieinces she is able to supervise graduate students and undertake collaborative research working with a number of veterinary species.
Availability
- Dr Allison Stewart is:
- Available for supervision
Fields of research
Qualifications
- Masters (Coursework) of Science, Ohio State University
- Doctor of Philosophy, Institution to be confirmed
Research interests
-
Endocrinology, fungal disease, neurology, infectious disease, pharmacology, electrolyte imbalance
Works
Search Professor Allison Stewart’s works on UQ eSpace
2026
Conference Publication
Transport and management of a down horse
Stewart, Allison (2026). Transport and management of a down horse. American College of Veterinary Internal Medicine, Seattle, WA, United States, 10-13 June 2026.
2026
Journal Article
Use of SGLT2 inhibitors in horses with hyperinsulinaemic laminitis
Stewart, Allison (2026). Use of SGLT2 inhibitors in horses with hyperinsulinaemic laminitis. The Equine Veterinary Practitioner, 51 (2), 33-37.
2026
Conference Publication
How to perform a thorough ophthalmic exam
Stewart, Allison (2026). How to perform a thorough ophthalmic exam. New Zealand Veterinary Association Conference, Auckland, New Zealand, 23-25 May 2026.
2026
Conference Publication
Generalised cutaneous hypersensitivity reaction to dying Habronema spp. larvae in a 6-year-old horse with recurrent penile habronemiasis
Sullivan, Samara, Stewart, Allison, Wise, Jessica, Flood, Jordan, Thirioun, Marthe, Hodgson, Evelyn, Naseem, Noman and Noble, Laurance (2026). Generalised cutaneous hypersensitivity reaction to dying Habronema spp. larvae in a 6-year-old horse with recurrent penile habronemiasis. Australian Veterinary Conference, Brisbane, QLD, Australia, 18-21 May 2026.
2026
Conference Publication
Insect bite hypersensitivity: current therapies, owner experiences and information sourcing
Roebig, Macada, Randhawa, Imtiaz and Stewart, Allison (2026). Insect bite hypersensitivity: current therapies, owner experiences and information sourcing. Australian Veterinary Conference, Brisbane, QLD, Australia, 18-21 May 2026.
2026
Journal Article
Survey describing the perspectives and practices of Australian veterinarians to pain management in horses
Whitelock, A., Goodwin, W., Dryburgh, L., Mshelbwala, P. P., Rae, L., Marwedel, L., Lok, T., Kemp, K. and Stewart, A. J. (2026). Survey describing the perspectives and practices of Australian veterinarians to pain management in horses. Australian Veterinary Journal, 104 (5), 287-297. doi: 10.1111/avj.70059
2026
Journal Article
Topical cream with essential oils, zinc and salicylic acid reduces pruritus and skin lesion scores in pruritic dogs
Prescott, D., Stewart, A., Schoep, A. and Herndon, A. (2026). Topical cream with essential oils, zinc and salicylic acid reduces pruritus and skin lesion scores in pruritic dogs. Australian Veterinary Journal, 104 (4) avj.70048, 196-205. doi: 10.1111/avj.70048
2026
Journal Article
Recommendation for the diagnosis and management of pituitary pars intermedia dysfunction, insulin dysregulation and equine metabolic syndrome
Stewart, Allison, Bertin, Francois-Rene, Tan, Rachel, de Laat, Melody, Hughes, Kristopher, Bailey, Simon, Sonia, Jenny and Bamford, Nicholas (2026). Recommendation for the diagnosis and management of pituitary pars intermedia dysfunction, insulin dysregulation and equine metabolic syndrome. Australian Equine Veterinarian, 47 (1), 34-53.
2026
Journal Article
Prolonged wireless measurement of intragastric pH in foals
Hodgson, Evelyn, Romano, Tallia-Rume, Stewart, Allison, Bond, Stephanie and Wise, Jessica (2026). Prolonged wireless measurement of intragastric pH in foals. Journal of Veterinary Internal Medicine, 40 (1) aalaf012. doi: 10.1093/jvimsj/aalaf012
2025
Journal Article
Antimicrobial prescribing guidelines for horses in Australia
Hardefeldt, L., Thomas, K., Page, S., Norris, J., Browning, G., El Hage, C., Stewart, A., Gilkerson, J., Muscatello, G., Verwilghen, D., van Galen, G., Bauquier, J., Cuming, R., Reynolds, B., Whittaker, C., Wilkes, E., Clulow, J., Burden, C. and Begg, L. (2025). Antimicrobial prescribing guidelines for horses in Australia. Australian Veterinary Journal, 103 (12), 781-889. doi: 10.1111/avj.70003
2025
Journal Article
A comparison of transdermal EMLA (lidocaine/prilocaine) cream and subcutaneous lidocaine injection prior to jugular vein catheterisation in horses – a randomised cross over study
Amiet, Biancia, Rainger, Joanne, Zedler, Steven, Stewart, Allison, Woldeyohannes, Solomon and Goodwin, Wendy (2025). A comparison of transdermal EMLA (lidocaine/prilocaine) cream and subcutaneous lidocaine injection prior to jugular vein catheterisation in horses – a randomised cross over study. Veterinary Anaesthesia and Analgesia, 52 (6), 933-940. doi: 10.1016/j.vaa.2025.06.009
2025
Conference Publication
Antibiogram development and multiple-drug-resistant bacteria of equine synovial infections
Tripcony, Shani, Gibson, Justine and Stewart, Allison J. (2025). Antibiogram development and multiple-drug-resistant bacteria of equine synovial infections. Australian and New Zealand College of Veterinary Specialists- Science Week, Gold Coast, QLD, Australia, 24-27 July 2025.
2025
Conference Publication
Orthoflavivirus infections in juvenile horses
Wang, Xueli, Meers, Joanne, Wise, Jessica and Stewart, Allison J. (2025). Orthoflavivirus infections in juvenile horses. Australian and New Zealand College of Veterinary Specialists Science Week 2025, Gold Coast, QLD, Australia, 24 - 27 July 2025.
2025
Conference Publication
Insect bite hypersensitivity: owner versus veterinarian disease scoring
Roebig, Macada, Cox, Abbey, Randhowa, Imtiaz and Stewart, Allison J. (2025). Insect bite hypersensitivity: owner versus veterinarian disease scoring. Australian and New Zealand College of Veterinary Specialists Science Week 2025, Gold Coast, QLD, Australia, 24 - 27 July 2025.
2025
Conference Publication
Update on tests used to diagnose insulin dysregulation in the field
Clark, Brianna, Burtin, Francois-Rene and Stewart, Allison J. (2025). Update on tests used to diagnose insulin dysregulation in the field. Australian and New Zealand College of Veterinary Specialists Science Week 2025, Gold Coast, QLD, Australia, 24 - 27 July 2025.
2025
Conference Publication
Prolonged wireless measurement of intragastric pH in foals
Hodgson, Evie, Romano, Tallia-Rume, Stewart, Allison J., Bond, Steph and Wise, Jessica (2025). Prolonged wireless measurement of intragastric pH in foals. Australian and New Zealand College of Veterinary Specialists- Science Week, Gold Coast, QLD, Australia, 24-27 July 2025.
2025
Conference Publication
Perspectives and practices of Australian veterinarians to pain management in horses
Stewart, Allison J. and Flood, Jordan (2025). Perspectives and practices of Australian veterinarians to pain management in horses. Equine Veterinarians of Australia, Bain Fallon Memorial Conference, Sunshine Coast, QLD, Australia, 21-24 July 2025.
2025
Conference Publication
Development of an antibiogram and multidrug resistant bacteria in equine synovial infections- WINNER EVA Research Based Poster Prize for
Tripcony, Shani, Gibson, Justine, Randhowa, Imtiaz, Clark, Rachael and Stewart, Allison J. (2025). Development of an antibiogram and multidrug resistant bacteria in equine synovial infections- WINNER EVA Research Based Poster Prize for. Equine Veterinarians of Australia, Bain Fallon Memorial Conference, Sunshine Coast, QLD, Australia, 21-24 July 2025.
2025
Conference Publication
Severe necrotizing laryngitis of unknown origin in a 9-year-old Warmblood gelding
Thirouin, Marthe, Wang, Xueli, Ahern, Ben, Stewart, Allison J. and Wise, Jessica (2025). Severe necrotizing laryngitis of unknown origin in a 9-year-old Warmblood gelding. Equine Veterinarians of Australia, Bain Fallon Memorial Conference, Sunshine Coast, QLD, Australia, 21-24 July 2025.
2025
Conference Publication
Primary meningeal lymphoma of a 5-year-old Percheron mare
Flood, Jordan, Wise, Jessica, Young, Alex, Wang, Xueli and Stewart, Allison J. (2025). Primary meningeal lymphoma of a 5-year-old Percheron mare. Equine Veterinarians of Australia, Bain Fallon Memorial Conference, Sunshine Coast, QLD, Australia, 21-24 July 2025.
Funding
Current funding
Supervision
Availability
- Dr Allison Stewart is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Available projects
-
Determining the presence and persistence of colostral transfer of passive immunity against Hendra virus in foals, and their response to Hendra vaccination.
Potential Honours, Masters or PhD project for graduates of Veterinary Science, Veterinary Technology, Equine Science, Agricultural Science or Science degrees. Previous horse handling experience is required. Hendra virus (HeV) is a uniquely Australian emerging zoonotic virus of horses, posing significant economic, animal welfare, and public health concerns. The virus is transmitted from bats to horses.
An equine vaccine Equivac® HeV is available and antibody titres greater than 1:32 are considered protective. There have been no HeV cases in vaccinated horses. As there is no human vaccine for HeV, the most effective means of preventing human infection is through vaccination of horses. All horses at UQ are vaccinated, with foals vaccinated at 4-6 months of age.
Immunity in the equine neonate is conferred via transfer of passive immunoglobulins through ingestion of colostrum. Maternal antibody titres in foals may offer a short period of protection against HeV. The ideal time to vaccinate foals is unknown. The project will involve bleeding foals at birth and then every month until vaccination. Blood samples will also be collected after vaccination of different aged foals. HeV titres will be measured. PhD level projects may also involve laboratory work in the validation of other diagnostic tests to measure HeV antibody titres.
Please contact Allison Stewart allison.stewart@uq.edu.au. Graduate student salary and tuition support is currently not included in the funds available for this project. Australian and Commonwealth students may be eligible for scholarships. We would welcome international students with home country financial support (academic performance greater than B+ and IELTS >6.5 overall and > 6 in each category). Limited UQ scholarships for international students are available for high outstanding applicants.
Graduate student salary and tuition support is currently not included in the funds available for this project. Australian and Commonwealth students may be eligible for scholarships. We would welcome international students with home country financial support (academic performance greater than B+ and IELTS >6.5 overall and > 6 in each category). Limited UQ scholarships for international students are available for high outstanding applicants.
-
Comparison of the effects of storage and temperature on the stability of Australian liquid formulations of pergolide.
PPID is a common disease afflicting horses (and ponies) throughout the world, with more than 20% of horses older than 15 years affected. Clinical signs of PPID include hypertrichosis, chronic infections; hyper- or anhydrosis and recurrent laminitis. Laminitis is a painful and incurable condition of horses resulting in loss of use, high veterinary and farrier expenses and decreased survival.
The dopamine agonist pergolide mesylate provides the most effective treatment for PPID. Dosages used to successfully control PPID range from 1 to 5 mg of pergolide daily. Treatment success is considered to be resolution of clinical signs and normalization of ACTH concentrations. There are anecdotal reports of high rates of treatment failures in horses and ponies being treated with liquid pergolide products. This may be because of inadequate dose or degraded drug because of inappropriate storage conditions and delays between manufacture and administration.
Concentrations of pergolide in various commercially available products will be measured after exposure to various temperatures and periods of time using liquid chromatography-mass spectrometry (LC-MS).
PPID is a common disease afflicting horses (and ponies) throughout the world, with more than 20% of horses older than 15 years affected. Clinical signs of PPID include hypertrichosis, chronic infections; hyper- or anhydrosis and recurrent laminitis. Laminitis is a painful and incurable condition of horses resulting in loss of use, high veterinary and farrier expenses and decreased survival.
Elevated basal plasma adrenocorticotropic hormone (ACTH) concentration is used to diagnose PPID. The dopamine agonist pergolide mesylate provides the most effective treatment for PPID. Dosages used to successfully control PPID range from 1 to 5 mg of pergolide daily. Treatment success is considered to be resolution of clinical signs and normalization of ACTH concentrations. There are anecdotal reports of high rates of treatment failures in horses and ponies being treated with liquid pergolide products. This may be because of inadequate dose or degraded drug because of inappropriate storage conditions and delays between manufacture and administration.
The proposed piolet study would enrol client owned horses and ponies with PPID. ACTH concentration will be periodically measured after treatment with a liquid and tablet formulations of pergolide. A dose escalation study will be performed until clinical signs and ACTH concentrations improve. The efficacy of liquid and tablet formulations of pergolide will be compared.
Graduate student salary and tuition support is currently not included in the funds available for this project. Australian and Commonwealth students may be eligible for scholarships. We would welcome international students with home country financial support (academic performance greater than B+ and IELTS >6.5 overall and > 6 in each category). Limited UQ scholarships for international students are available for high outstanding applicants.
-
Pilot study determining the efficacy of two commercial formulations of pergolide to treat Pituitary pars intermedia dysfunction (PPID) in horses.
PPID is a common disease afflicting horses (and ponies) throughout the world, with more than 20% of horses older than 15 years affected. Clinical signs of PPID include hypertrichosis, chronic infections; hyper- or anhydrosis and recurrent laminitis. Laminitis is a painful and incurable condition of horses resulting in loss of use, high veterinary and farrier expenses and decreased survival.
Elevated basal plasma adrenocorticotropic hormone (ACTH) concentration is used to diagnose PPID. The dopamine agonist pergolide mesylate provides the most effective treatment for PPID. Dosages used to successfully control PPID range from 1 to 5 mg of pergolide daily. Treatment success is considered to be resolution of clinical signs and normalization of ACTH concentrations. There are anecdotal reports of high rates of treatment failures in horses and ponies being treated with liquid pergolide products. This may be because of inadequate dose or degraded drug because of inappropriate storage conditions and delays between manufacture and administration.
The proposed piolet study would enrol client owned horses and ponies with PPID. ACTH concentration will be periodically measured after treatment with a liquid and tablet formulations of pergolide. A dose escalation study will be performed until clinical signs and ACTH concentrations improve. The efficacy of liquid and tablet formulations of pergolide will be compared.
PPID is a common disease afflicting horses (and ponies) throughout the world, with more than 20% of horses older than 15 years affected. Clinical signs of PPID include hypertrichosis, chronic infections; hyper- or anhydrosis and recurrent laminitis. Laminitis is a painful and incurable condition of horses resulting in loss of use, high veterinary and farrier expenses and decreased survival.
Elevated basal plasma adrenocorticotropic hormone (ACTH) concentration is used to diagnose PPID. The dopamine agonist pergolide mesylate provides the most effective treatment for PPID. Dosages used to successfully control PPID range from 1 to 5 mg of pergolide daily. Treatment success is considered to be resolution of clinical signs and normalization of ACTH concentrations. There are anecdotal reports of high rates of treatment failures in horses and ponies being treated with liquid pergolide products. This may be because of inadequate dose or degraded drug because of inappropriate storage conditions and delays between manufacture and administration.
The proposed piolet study would enrol client owned horses and ponies with PPID. ACTH concentration will be periodically measured after treatment with a liquid and tablet formulations of pergolide. A dose escalation study will be performed until clinical signs and ACTH concentrations improve. The efficacy of liquid and tablet formulations of pergolide will be compared.
Graduate student salary and tuition support is currently not included in the funds available for this project. Australian and Commonwealth students may be eligible for scholarships. We would welcome international students with home country financial support (academic performance greater than B+ and IELTS >6.5 overall and > 6 in each category). Limited UQ scholarships for international students are available for high outstanding applicants.
Supervision history
Current supervision
-
Doctor Veterinary Clinical Sci
Assessment of the diagnostic accuracy and clinical efficacy of adrenocorticotropic hormone (ACTH) and thyrotropin-releasing hormone (TRH)-stimulated ACTH testing of Pituitary Pars Intermedia Dysfunction (PPID) in horses managed in subtropical Queensland.
Principal Advisor
Other advisors: Dr Steph Bond
-
Doctor Veterinary Clinical Sci
Efficacy of eluted ophthalmic drugs against common equine ocular isolates
Principal Advisor
Other advisors: Dr Justine Gibson, Dr Noman Naseem
-
Doctor Philosophy
Testing Student Learning Outcomes and Preparedness for Clinical Practice Using Virtual Reality-Based Training
Principal Advisor
Other advisors: Dr Frances Shapter, Associate Professor Sobia Zafar
-
Master Philosophy
Studies into the Diagnosis of Insect Bite Hypersensitivity (IBH) in Horses
Principal Advisor
Other advisors: Dr Aaron Herndon
-
Doctor Veterinary Clinical Sci
Investigation of a novel pharmaceutical treatment option for Equine Gastric Ulcer Syndrome
Principal Advisor
Other advisors: Professor Paul Mills, Dr Steph Bond
-
Doctor Veterinary Clinical Sci
A novel placement method of the Bravo calibration-free reflux capsule for measuring intragastric pH wirelessly in horses
Associate Advisor
Other advisors: Dr Steph Bond
-
Doctor Philosophy
Unveiling the Immune Response in Horses: Paving the Way for Biomarker Discovery and Sustainable Control of Insect Bite Hypersensitivity
Associate Advisor
Other advisors: Dr Swaid Abdullah, Dr Noman Naseem
Completed supervision
-
2026
Doctor Veterinary Clinical Sci
Maternal antibody decline and natural orthoflavivirus infection in foals
Principal Advisor
Other advisors: Associate Professor François-René Bertin
-
2025
Doctor Veterinary Clinical Sci
Antimicrobial use and stewardship in dog-to-dog bite wounds
Principal Advisor
Other advisors: Dr Justine Gibson
-
2026
Doctor Philosophy
The Role of Hypothalamic Dopaminergic Degeneration in Intestinal Health in Horses with Pituitary Pars Intermedia Dysfunction
Associate Advisor
Other advisors: Dr Justine Gibson, Dr Deirdre Mikkelsen, Dr Viviana Gonzalez Astudillo, Associate Professor François-René Bertin
-
2024
Doctor Philosophy
Investigating insulin and glucose dynamics in horses with insulin dysregulation receiving phenylbutazone
Associate Advisor
Other advisors: Professor Paul Mills, Associate Professor François-René Bertin
-
2023
Doctor Veterinary Clinical Sci
Epidemiological and genetic investigation of insulin dysregulation in ponies
Associate Advisor
Other advisors: Associate Professor François-René Bertin
Media
Enquiries
For media enquiries about Dr Allison Stewart's areas of expertise, story ideas and help finding experts, contact our Media team: